Axonics Modulation Technologies Stock Price To Earning
| AXNXDelisted Stock | USD 70.98 0.48 0.68% |
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Price To Earning Analysis
Axonics Modulation's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Axonics Modulation Price To Earning | (10.68) X |
Most of Axonics Modulation's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Axonics Modulation Technologies has a Price To Earning of -10.6773 times. This is 141.32% lower than that of the Health Care Equipment & Supplies sector and 115.28% lower than that of the Health Care industry. The price to earning for all United States stocks is 137.18% higher than that of the company.
Axonics Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in price to earning category among its peers.
Axonics Fundamentals
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 3.32 B | ||||
| Shares Outstanding | 51.11 M | ||||
| Shares Owned By Insiders | 1.26 % | ||||
| Shares Owned By Institutions | 87.22 % | ||||
| Number Of Shares Shorted | 3.31 M | ||||
| Price To Earning | (10.68) X | ||||
| Price To Book | 5.46 X | ||||
| Price To Sales | 8.40 X | ||||
| Revenue | 366.38 M | ||||
| Gross Profit | 197.66 M | ||||
| EBITDA | 7.78 M | ||||
| Net Income | (6.09 M) | ||||
| Cash And Equivalents | 213.23 M | ||||
| Cash Per Share | 4.53 X | ||||
| Total Debt | 27.62 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 10.49 X | ||||
| Book Value Per Share | 13.00 X | ||||
| Cash Flow From Operations | (2.02 M) | ||||
| Short Ratio | 7.14 X | ||||
| Earnings Per Share | (0.10) X | ||||
| Price To Earnings To Growth | (0.56) X | ||||
| Target Price | 72.0 | ||||
| Number Of Employees | 797 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 3.63 B | ||||
| Total Asset | 719.92 M | ||||
| Retained Earnings | (380.35 M) | ||||
| Working Capital | 445.61 M | ||||
| Current Asset | 171.14 M | ||||
| Current Liabilities | 12.98 M | ||||
| Net Asset | 719.92 M |
About Axonics Modulation Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axonics Modulation Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axonics Modulation using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axonics Modulation Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |